Evidence map›Paper›PMID 24416718›Full record

ArticleRedox biology2013

Mild exposure of RIN-5F β-cells to human islet amyloid polypeptide aggregates upregulates antioxidant enzymes via NADPH oxidase-RAGE: an hormetic stimulus.

Elisabetta Borchi, Valentina Bargelli, Valentina Guidotti, Andrea Berti, Massimo Stefani, Chiara Nediani, Stefania Rigacci

Abstract read
In one paragraph

Article in Redox biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Ashwagandha (Iranian journal of basic medical sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Oleuropein, a Bioactive Compound fromAntioxidants (Basel, Switzerland) · 2019
    Review
  8. Review
  9. When less is more: hormesis against stress and disease.Microbial cell (Graz, Austria) · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elisabetta BorchiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Valentina BargelliDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Valentina GuidottiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Andrea BertiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy ; Research Centre on the Molecular Basis of Neurodegeneration (CIMN), Viale Morgagni 50, 50134 Florence, Italy.
Massimo StefaniDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy ; Research Centre on the Molecular Basis of Neurodegeneration (CIMN), Viale Morgagni 50, 50134 Florence, Italy ; National Institute of Biostructures and Biosystems (INBB), Viale Medaglie d'Oro 305, Rome, Italy.
Chiara NedianiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Stefania RigacciDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of amyloid aggregates of human islet amyloid polypeptide (hIAPP), a hallmark of type 2 diabetes, contributes to pancreatic β-cell impairment, where oxidative stress plays a key role. A contribution of NADPH oxidase to reactive oxygen species (ROS) generation after cell exposure to micromolar concentrations of hIAPP aggregates has been suggested. However, little is known about β-cells exposure to lower amounts of hIAPP aggregates, similar to those found in human pancreas. Thus, we aimed to investigate the events resulting from RIN-5F cells exposure to nanomolar concentrations of toxic hIAPP aggregates. We found an early and transient rise of NADPH oxidase activity resulting from increased Nox1 expression following the engagement of receptor for advanced glycation end-products (RAGE) by hIAPP aggregates. Unexpectedly, NADPH oxidase activation was not accompanied by a significant ROS increase and the lipoperoxidation level was significantly reduced. Indeed, cell exposure to hIAPP aggregates affected the antioxidant defences, inducing a significant increase of the expression and activity of catalase and glutathione peroxidase. We conclude that exposure of pancreatic β-cells to nanomolar concentrations of hIAPP aggregates for a short time induces an hormetic response via the RAGE-Nox1 axis; the latter stimulates the enzymatic antioxidant defences that preserve the cells against oxidative stress damage.

Indexed as

AnimalsCatalaseCell Line, TumorGlutathione PeroxidaseInsulin-Secreting CellsIslet Amyloid PolypeptideLipid PeroxidationNADPH OxidasesOxidative StressRatsReactive Oxygen SpeciesReceptor for Advanced Glycation End ProductsReceptors, ImmunologicSuperoxide DismutaseUp-RegulationCatalaseGlutathione PeroxidaseIslet Amyloid PolypeptideNADPH OxidasesReactive Oxygen SpeciesReceptor for Advanced Glycation End ProductsReceptors, ImmunologicSuperoxide DismutaseAGE, advanced glycation end productsAntioxidant enzymeATZ, 3-amino-1,2,4-triazoleCAT, catalaseDPI, diphenyleneiodoniumGPx, glutathione peroxidasehIAPPhIAPP, human islet amyloid polypeptideHormesisMDA, malonyldialdehydeMS, mercaptosuccinic acidNADPH oxidaseRAGERAGE, receptor for advanced glycation end-productsrIAPP, rat islet amyloid polypeptideROS, reactive oxygen speciesSOD, superoxide dismutaseType 2 diabetes

Identifiers

PMID24416718
PMCPMC3887275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.